Phase II study of olaparib in patients with refractory Ewing sarcoma following failure of standard chemotherapy

Overview of attention for article published in BMC Cancer, November 2014

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

f1000: 1 research highlight platform

Citations

dimensions_citation: 135 Dimensions

Readers on

mendeley: 109 Mendeley

Summary Research highlights Dimensions citations

So far, Altmetric has seen 1 review on a research highlight platform.

Recommended in Faculty Opinions

18 Aug 2016

This research output was recommended by a member of Faculty Opinions.

This page shows the most recent research highlights that mention this research output.

Click here to find out how to access more activity.